drugset / Trial / NCT00189059

Effects of Amitriptyline for the Treatment of Pain on Driving Performance and Cognition.

NCT00189059

Phase 4 Terminated 24 enrolled UMC Utrecht Utrecht University · collab
RandomizedCrossoverDouble-blindTreatment

Summary

The acute and subchronic effects of amitriptyline were compared to placebo in a double-blind crossover randomized study on driving ability and driving-related skills in chronic neuropathic pain patients.It was hypothesized that nocturnally administered 25 mg amitriptyline might affect driving performance negatively after acute, but not after subchronic treatment.

Timeline

Start
2002-10
Primary completion
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Amitriptyline Small molecule 25 mg

Indications